Last $3.83 USD
Change Today -0.04 / -1.03%
Volume 93.1K
LBMH On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

liberator medical holdings i (LBMH) Snapshot

Open
$3.87
Previous Close
$3.87
Day High
$3.87
Day Low
$3.79
52 Week High
03/4/14 - $4.56
52 Week Low
08/20/14 - $2.30
Market Cap
203.6M
Average Volume 10 Days
202.6K
EPS TTM
$0.16
Shares Outstanding
53.2M
EX-Date
03/24/15
P/E TM
23.9x
Dividend
$0.13
Dividend Yield
3.26%
Current Stock Chart for LIBERATOR MEDICAL HOLDINGS I (LBMH)

Related News

No related news articles were found.

liberator medical holdings i (LBMH) Related Businessweek News

No Related Businessweek News Found

liberator medical holdings i (LBMH) Details

Liberator Medical Holdings, Inc., together with its subsidiaries, distributes direct-to-consumer durable medical supplies for seniors and others with chronic illness in the United States. The company supplies urological catheters, ostomy supplies, diabetic medical supplies, and mastectomy fashions. It bills Medicare and third-party insurers on behalf of its patients. The company markets its products directly to consumers, primarily through targeted media, direct-response television, Internet, and print advertising. Liberator Medical Holdings, Inc. was founded in 1906 and is based in Stuart, Florida.

327 Employees
Last Reported Date: 02/9/15
Founded in 1906

liberator medical holdings i (LBMH) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $628.4K
Chief Financial Officer and Vice President
Total Annual Compensation: $420.7K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $279.1K
Compensation as of Fiscal Year 2014.

liberator medical holdings i (LBMH) Key Developments

Liberator Medical Holdings, Inc. Approves Cash Dividend, Payable on April 10, 2015

Liberator Medical Holdings, Inc. announced that on February 23, 2015, its Board of Directors approved a cash dividend of $0.0325 per common share to its shareholders. The dividend will be paid on April 10, 2015, to all shareholders of record as of the close of business on March 26, 2015.

Liberator Medical Holdings, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2014

Liberator Medical Holdings, Inc. announced unaudited consolidated earnings results for the first quarter ended December 31, 2014. Net sales for the three months ended December 31, 2014, increased by $1,579,000, or 8.5%, to $20,216,000, compared with net sales of $18,637,000 for the three months ended December 31, 2013. The increase in Net Sales were primarily due to its continued emphasis on its direct response advertising campaign to acquire new customers and its emphasis on customer service to maximize the reorder rates for its recurring customer base. Income from operations for the three months ended December 31, 2014, increased by $484,000, or 13.8%, to $3,984,000, compared with $3,500,000 for the three months ended December 31, 2013. The increase in operating income is primarily attributed to increased gross profits driven by its increased sales volumes as well as reductions in payroll costs as a percentage of net sales and decreased general and administration expenses. Net income for the first quarter of fiscal year 2015 was $2,421,000 or $0.05 per diluted share, compared with net income of $2,120,000 or $0.04 per diluted share, for the first quarter of fiscal year 2013, an increase of 14.2%. Income before income taxes was $3.972 million against $3.487 million a year ago. Net cash flow provided by operating activities was $1.460 million against $1.307 million a year ago. Purchase of property and equipment was $13,000 against $51,000 a year ago.

Liberator Medical Holdings, Inc. Reports Consolidated Earnings Results for the Year Ended September 30, 2014

Liberator Medical Holdings, Inc. reported consolidated earnings results for the year ended September 30, 2014. For the year, the company's net sales were $74,569,000 against $69,111,000 a year ago. Income from operations was $12,709,000 against $11,759,000 a year ago. Income before income taxes was $12,659,000 against $11,676,000 a year ago. Net income was $7,802,000 or $0.15 basic and diluted per share against $7,078,000 or $0.14 basic and diluted per share a year ago. Net cash flows provided by operating activities was $5,528,000 against $13,633,000 a year ago. Purchase of property and equipment and other was $194,000 against $367,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LBMH:US $3.83 USD -0.04

LBMH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LBMH.
View Industry Companies
 

Industry Analysis

LBMH

Industry Average

Valuation LBMH Industry Range
Price/Earnings 25.4x
Price/Sales 2.7x
Price/Book 6.1x
Price/Cash Flow 23.4x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIBERATOR MEDICAL HOLDINGS I, please visit www.liberatormedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.